Division of Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Division of Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA,
Blood Purif. 2020;49(1-2):222-227. doi: 10.1159/000504081. Epub 2019 Dec 18.
Uremic pruritus (UP) and restless legs syndrome (RLS) are highly prevalent complaints among patients with end-stage renal disease (ESRD) undergoing chronic dialysis. These chronic troublesome symptoms lead to a significant decrease in quality of life (QOL) and increase in mortality rate. Despite their distressing characteristics, these symptoms usually remain under-recognized by healthcare providers. Therefore, careful history intake, and stepwise treatment are essential. Numerous pharmacological and non-pharmacological treatments have been demonstrated to help in controlling these 2 conditions.
In this review, we discuss the latest findings regarding UP and RLS among ESRD patients on maintenance dialysis. We also examine different treatment options in this group of patients. The majority of these patients do not have the opportunity to receive a kidney transplant and need other treatments for these burdensome symptoms in order to improve their QOL and prognosis. Key Messages: UP and RLS are common but underdiagnosed conditions in ESRD patients on maintenance dialysis that are related to a decline in patients' QOL and poor prognosis. The pathophysiology of these conditions remains not well understood. Therefore, controversies still exist on treatment options. Treating these conditions provides an opportunity to improve the health-related QOL and outcomes of dialysis patients.
尿毒症瘙痒(UP)和不宁腿综合征(RLS)是接受慢性透析的终末期肾病(ESRD)患者中非常常见的抱怨。这些慢性麻烦症状导致生活质量(QOL)显着下降和死亡率增加。尽管这些症状具有令人痛苦的特征,但这些症状通常仍然未被医疗保健提供者所认识。因此,仔细的病史采集和逐步治疗是必不可少的。已经证明许多药理学和非药理学治疗方法有助于控制这两种情况。
在这篇综述中,我们讨论了维持性透析的 ESRD 患者中 UP 和 RLS 的最新发现。我们还检查了该组患者的不同治疗选择。这些患者中的大多数没有机会接受肾移植,并且需要其他治疗方法来治疗这些负担过重的症状,以改善他们的 QOL 和预后。
UP 和 RLS 是维持性透析的 ESRD 患者中常见但诊断不足的疾病,与患者 QOL 下降和预后不良有关。这些病症的病理生理学仍未得到很好的理解。因此,在治疗选择上仍存在争议。治疗这些病症为改善透析患者的健康相关 QOL 和结果提供了机会。